Market narrative

Read the headlines around the signals.

Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.

Latest marketbeat.com · 2 days ago

RPC Q2 Earnings Call Highlights

RPC NYSE: RES reported second-quarter 2026 revenue of $461 million, up 1% sequentially, as growth in several technical-service lines and improved job mix supported a 250-basis-point increase in adjusted EBITDA margin.

Stocks

More recent coverage

Page 58
RYAN marketbeat.com · 2 days ago

Ryan Specialty Q2 Earnings Call Highlights

Ryan Specialty NYSE: RYAN reported second-quarter revenue growth of 7.2% to $917 million, supported by 6.7% organic growth and modest contributions from acquisitions, as the specialty insurance services company navigated pricing pressure in property insurance and rising competition in several markets.

SAFE marketbeat.com · 2 days ago

Safehold Q2 Earnings Call Highlights

Safehold NYSE: SAFE reported second-quarter results marked by increased ground lease originations, new private capital transactions and continued growth in its estimated unrealized capital appreciation account.

SONC marketbeat.com · 2 days ago

Sonic Automotive Q2 Earnings Call Highlights

Sonic Automotive NYSE: SAH reported record second-quarter revenue of $3.9 billion, up 8% from a year earlier, and all-time quarterly gross profit of $616.2 million, up 2%. Reported GAAP earnings were $1.79 per diluted share, while adjusted earnings were $1.82 per diluted share, Chairman and Chief Executive Officer David Smith said on the company's second-quarter 2026 earnings call.

CAPR businesswire.com · 2 days ago

Shareholder Alert - Robbins LLP Informs Investors of the Capricor Therapeutics, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)---- $CAPR #Biologics--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities between December 17, 2025 and July 26, 2026 (the "Class Period").The lawsuit alleges that Capricor Therapeutics misled investors regarding the path to FDA approval for its lead product candidate Deramiocel, a cell therapy to address cardiac and skeletal muscle compli.

UEC globenewswire.com · 2 days ago

Anfield Energy Closes US$6.9 million Underwritten Public Offering

VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- Anfield Energy Inc. ("Anfield" or the "Company") (TSX. V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) has closed its previously announced underwritten public offering (the "Offering") of 1,715,000 common shares (the "Common Shares"), which includes the full exercise of the underwriters' option to purchase an additional 233,695 Common Shares, at a price of US$4.

AEC globenewswire.com · 2 days ago

Anfield Energy Closes US$6.9 million Underwritten Public Offering

VANCOUVER, British Columbia, July 31, 2026 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (“Anfield” or the “Company”) (TSX.V: AEC; NASDAQ: AEC; FRANKFURT: 0AD) has closed its previously announced underwritten public offering (the “Offering”) of 1,715,000 common shares (the “Common Shares”), which includes the full exercise of the underwriters' option to purchase an additional 233,695 Common Shares, at a price of US$4.00 per Common Share for aggregate gross proceeds to the Company of US$6.9 million.

← Newer
Older →